GB 3232-1982
Abolished
T/GDPA 3-2024
Active
Group standards
T/GDPA 3-2024 Anti-tumor drug subcutaneous formulation full-process pharmacy service guidance
T/GDPA 3-2024 Anti-tumor drug subcutaneous formulation full-process pharmacy service guidance
Price:
$ 20.00
Basic Information
Standard Code:
T/GDPA 3-2024
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Hormones, family planning, anti-tumor drugs, and immunosuppressive drugs
ICS Name:
Integrated medical science and healthcare devices
Publish Date:
2024-05-11
Implement Date:
2024-05-18
Scope
Main technical content: This document is applicable to all levels and types of medical institutions that carry out subcutaneous administration of anti-tumor drugs for treatment. It mainly elaborates and writes guidelines for comprehensive pharmaceutical services from two aspects: the rational clinical use of drugs and the comprehensive management of adverse reactions, with the aim of providing reference for clinicians in making rational drug-use decisions, providing clear guidance for clinical nurses in standardized nursing operations, providing scientific reference standards for pharmacists in reviewing and evaluating prescription orders, and laying a solid foundation for medical institutions to carry out comprehensive evaluation research on new dosage forms of anti-tumor drugs
Development Information
Related Standards
GB 3233-1982
Abolished
GB 3233-1982 Diagnostic criteria and principles of management of occupational chronic carbon disulfide poisoning
GB 3234-1982
Abolished
GB 3234-1982 Diagnostic criteria and principles of management of industrial fluorosis
GB 4865-1985
Abolished
GB 4865-1985 Diagnostic criteria and principles of management of occupational chronic allyl chloride poisoning
GB 4869-1985
Abolished
GB 4869-1985 Diagnostic criteria and principles of management of occupational vibration disease
GB 5044-1985
Abolished